About the Author

Stephen Oakes is an experienced financial titan from New York who brings Wall Street to Main Street. Over the past 11 years, he has developed and tested the renown, Oakes Momentum System, which uses a unique constellation of technical indicators to find timely buy and sell points. He holds an M.B.A. in the United States (New York) and has studied internationally at the Reims School of Management in France.

See All Posts by This Author

Merck & Co. (MRK): Let’s roll the dice and play a lil’ Monopoly

April 5th, 2007 • Related • Filed Under

On March 22, 2007 I posted on the possibility of a surge in Merck stock. Technically we are not quite there yet, but shares are starting to move. It has climbed over a dollar since I mentioned it about two weeks ago.

Does this make the stock expensive? Not at all.

Shares are still very attractive and have been in a short-term consolidating phase. It is recommended that you initiate a position and protect your capital via 5% stop loss. This stock should rise about $10 in the six months to follow. A 22% return isn’t too shabby given the time frame.

MRK

Good Investing…

Comments are closed.